Cardiac-specific BACH1 ablation attenuates pathological cardiac hypertrophy by inhibiting the Ang II type 1 receptor expression and the Ca2+/CaMKII pathway.
Wei X, Jin J, Wu J, He Y, Guo J, Yang Z, Chen L, Hu K, Li L, Jia M, Li Q, Lv X, Ge F, Ma S, Wu H, Zhi X, Wang X, Jiang L, Osto E, Zhang J, Meng D.
Wei X, et al. Among authors: chen l.
Cardiovasc Res. 2023 Aug 7;119(9):1842-1855. doi: 10.1093/cvr/cvad086.
Cardiovasc Res. 2023.
PMID: 37279500